Search Results 111-120 of 18686 for amyloidosis

  1. A Study to Monitor Cardiac Amyloidosis Patients with Implantable Event Monitors - Mayo Clinic

    ... amyloidosis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  2. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    ... amyloidosis such as age-related amyloidosis or hereditary amyloidosis (ATTR mutation). Measurable disease of amyloid light chain amyloidosis as defined by ...

  3. Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

    The purpose of this study is to determine the prevalence of TTR-CA in a community-based cohort of moderate and severe aortic stenosis patients using 99mTc-PYP ...

  4. Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy - Mayo Clinic

    The purpose of this study is to provide expanded access of patisiran to patients with transthyretin-mediated amyloidosis (ATTR amyloidosis) with cardiomyopathy.

  5. A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease - Mayo Clinic

    A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease · Overview · Participation eligibility · Participating Mayo Clinic ...

  6. A Study to Evaluate the Effectiveness and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy - Mayo Clinic

    The purpose of this study is to evaluate vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. Participation eligibility. Participant ...

  7. Morie A. Gertz, M.D. - Mayo Clinic Faculty Profiles

    ... amyloidosis when being treated with novel versus traditional therapies. Focus areas. Primary amyloidosis; Stem cell transplantation in the treatment of ...

  8. Publications - Joanna C. Dalland, M.D. - Mayo Clinic

    Dual Amyloidosis: A Clinicopathologic and Proteomic Analysis of 111 Patients. ... Gallbladder amyloidosis is often unexpected and may have systemic implications.

  9. Spotlight on early detection of 3 heart diseases using ECG-AI - Mayo Clinic News Network

    ... amyloidosis, aortic stenosis, low ejection fraction, hypertrophic cardiomyopathy (HCM) and more. The AI can also predict a patient's biological age using ...

  10. Florida Chef Finds Expertise to Manage Rare Disease, Get His Life Back

    Amyloidosis occurs when a substance called amyloid builds up in the organs. ... Severe amyloidosis can lead to life-threatening organ failure. While ...